Prime Snippets
PRIME Magazine|Oct - Nov 2017

Latest medical news in brief

Prime Snippets

KOREAN START-UP SKY LABS SELECTED AS ONE OF THE WINNERS FOR BAYER GLOBAL GRANTS4APPS ACCELERATOR 2017

Sky Labs, a Korean start-up developing a subminiature ring-type atrial fibrillation (AF) diagnosis device ‘CART’ was selected as one of the winners along with three other digital health start-ups from United Kingdom and USA in the G4A Accelerator 2017 program, which fosters digital innovation in healthcare and supports start-up companies. Bayer received more than 450 digital health-related applications from 61 countries for this year, and applications from the US, Germany, Brazil and UK were extremely strong this year. This is also the second consecutive year that a Korean start-up has selected as one of the winners.

Sky Labs has been developing a ring-type device for accurate diagnosis and customized management of atrial fibrillation (AF), called CART (Cardio Tracker). AF is a chronic disease that affects one out of four people in their 40s or older, and may cause a stroke from which more than half of the patients die.

The winners will each receive financial support of EUR 50,000, mentoring and coaching by Bayer employees and external experts in Berlin to advance their digital health projects in areas, such as medical adherence, endometriosis, atrial fibrillation, deep vein thrombosis and ultrasound diagnostics until late November. Bayer senior managers and external experts will mentor and support the start-ups in further developing their business models and products during that time.

STUDY FINDS WOMEN’S BRAINS ARE FAR MORE ACTIVE THAN MEN’S

This story is from the Oct - Nov 2017 edition of PRIME Magazine.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

This story is from the Oct - Nov 2017 edition of PRIME Magazine.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.